Posted in | News | Quantum Dots | Nanomaterials

Patent Landscape Overview of Nanoparticles for Bio-Imaging

Research and Markets (http://www.researchandmarkets.com/research/6f3dd1/nanoparticles_for) has announced the addition of the "Nanoparticles for Bioimaging Patent Landscape 2010" report to their offering.

IP Overview NP for bioimaging presents a patent landscape analysis of the nanoparticles in bioimaging field.

In the current development of imaging technologies, new contrast agents and tracers are necessary to improve visualization. Nanoparticles appear to have the highest potential because they can combine multiple properties such as magnetic, luminescent, radioactive and even therapeutic properties.

At present, three imaging nanoparticles have been approved for commercialization and biomedical diagnostic use. Two have been developed by Amag Pharmaceuticals (treated separately in this study) and one by Bayer. Market segments are therefore still to conquer which resulted in a very high research and patenting activity in the last years.

Institutional applicants have a specific positioning on the sector, while only important industrial structures of the imaging field build up their portfolio notably in the US and Europe. On specific segments, Asian applicants are noticeably emerging.

The present report analyses the patent environment and notably highlights the various types of nanoparticles (magnetic, quantum dot) that have been developed and their potential applications in bio-imaging. IP strategies of the different players seem to show an underlying trend to claim nanoparticles combining multiple properties and covering a large range of applications. In some cases, this situation can act as a blockage for future filings.

In a sector where more than 800 patents and patent applications have been filed, this IP Overview Nanoparticles for bio-imaging, provides you with a comprehensive panorama of the intellectual property landscape and helps you:

  • Position your company's R&D and IP Portfolio
  • Identify key inventors and key players involved in the development of specific nanoparticles
  • Understand the collaboration networks and their dynamics
  • Uncover trends and emerging segments

Source: http://www.researchandmarkets.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.